Dr. Bunick is an Associate Professor of Dermatology at Yale School of Medicine. He specializes in general medical dermatology and dermatologic surgery, while also leading dermatology clinical trials. He performs unique dermatologic research studying the three-dimensional structures of skin-related proteins and therapeutics using x-ray crystallography and cryo-electron microscopy. Dr. Bunick received his B.S., M.D., and Ph.D. at Vanderbilt University. He completed internship, dermatology residency, and a dermatology research fellowship at Yale School of Medicine.

Disclosures:
Investigator and/or consultant for AbbVie, AbSci, Almirall, Alumis, Amgen, Apogee, Arcutis, Botanix, Castle Biosciences, Connect BioPharma, Daiichi Sankyo, Dermavant, Disc Medicine, Eli Lilly, EPI Health/Novan, Galderma, Highlight Therapeutics, Incyte, LEO Pharma, Novartis, Ortho Dermatologics, Palvella, Pfizer, Priovant, Regeneron, Sanofi, South Beach Symposium, Sun Pharma, Takeda, Timber, Teladoc, Triveni, UCB, and Veradermics.